Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
11 hedge funds and large institutions have $351K invested in Guardion Health Sciences, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
21% less funds holding
Funds holding: 14 → 11 (-3)
29% less capital invested
Capital invested by funds: $498K → $351K (-$146K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4.01K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$10.3K |
| 2 |
Barclays
London,
United Kingdom
|
-$5.48K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$133 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $203K | -$10.3K | -1,700 | -4% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $79.3K | – | – | – |
|
3
BlackRock
New York
| $53.6K | – | – | – |
|
|
4
Morgan Stanley
New York
| $7.04K | +$4.01K | +659 | +100% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $6.08K | +$1.04K | +171 | +18% |
|
6
Citigroup
New York
| $1.95K | – | – | – |
|
|
CPG
7
Cornerstone Planning Group
Fairfield,
New Jersey
| $198 | – | – | – |
|
|
S
8
SignatureFD
Atlanta,
Georgia
| $107 | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $91 | – | – | – |
|
10
Wells Fargo
San Francisco,
California
| $48 | – | – | – |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $32 | – | – | – |
|
|
12
Barclays
London,
United Kingdom
| – | -$5.48K | -742 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$133 | -18 | Closed |
|
GHSI Hedge Fund Activity: Q4 2023 in Review
11 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q4 2023, worth a combined $351K — down 29% from $498K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GHSI and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $4.01K. The largest seller was Renaissance Technologies, cutting an estimated $10.3K.
- 11 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q4 2023, down from 14 in Q3 2023.
- Funds reported $351K of Guardion Health Sciences, Inc. Common Stock stock for Q4 2023, down 29% quarter-over-quarter.
- 0 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q4 2023 and 3 closed out, a net change of -3 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $4.01K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q4 2023 was Renaissance Technologies, an estimated $10.3K sold.
Based on aggregated 13F filings for Q4 2023.